| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 26, 2021 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $0.56 | 33,000 |
| May 26, 2021 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 200,000 |
| May 12, 2021 |
Director, President and CEO
Trans History: 32
|
Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 290,000 | -- | 295,191 |
| May 12, 2021 |
Director, President and CEO
Trans History: 32
|
Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 290,000 | -- | 585,191 |
| May 12, 2021 |
Chief Operating Officer
Trans History: 21
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 240,000 | -- | 252,086 |
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 14
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 10,000 | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 14
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 5,000 | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 14
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 10,210 | -- | -- |
| Apr 01, 2021 |
Chief Medical Officer
Trans History: 14
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 275,000 | -- | 275,000 |
| Apr 01, 2021 |
Director, President and CEO
Trans History: 32
|
Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 775,000 | -- | 775,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.